Bristol Myers Squibb reports positive topline QUINTESSENTIAL Phase 2 results
Bristol Myers Squibb says it has positive topline results from the registrational Phase 2 QUINTESSENTIAL trial.
Story updates
11:00:35 AM UTC
SquawkNews
Bristol-Myers Squibb Company: Phase 2 Trial Met Primary Endpoint Of Overall Response Rate And Complete Response Rate
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.